Skip to main content
. 2022 Jul 28;19:94. doi: 10.1186/s12966-022-01333-w

Table 1.

Participant characteristics

Women (n = 253) Men (n = 462)
Categorical variables Count Column % Count Column%
WHO disease severity class (acute COVID-19 severity)a Class 3–4 72 28.5% 67 14.5%
Class 5 89 35.2% 166 35.9%
Class 6 38 15.0% 78 16.9%
Class 7–9 54 21.3% 151 32.7%
Recovery cluster Cluster 4: Mild 38 15.0% 48 10.4%
Cluster 3: Moderate 50 19.8% 58 12.6%
Cluster 2: Severe 31 12.3% 58 12.6%
Cluster 1: Very Severe 66 26.1% 172 37.2%
Missing 68 26.9% 126 27.3%
Comorbidities No comorbidity 71 28.1% 134 29.0%
1 comorbidity 53 20.9% 92 19.9%
2 + comorbidities 129 51.0% 236 51.1%
Ethnicity White 175 69.2% 324 70.4%
South Asian 32 12.6% 60 13.0%
Black 28 11.1% 21 4.6%
Other 11 4.3% 32 7.0%
Missing 7 2.8% 23 5.0%
IMD (quintile)b 1 (most deprived) 37 14.7% 98 21.2%
2 59 23.4% 107 23.2%
3 55 21.8% 72 15.6%
4 46 18.3% 95 20.6%
5 (least deprived) 55 21.8% 90 19.5%
Number of days where a 10-min moderate-intensity bout of physical activity was undertaken 0 139 55.8% 199 44.2%
1 48 19.3% 82 18.2%
2 28 11.2% 58 12.9%
3 +  34 13.7% 111 24.7%
Number of days where a 30-min bout of moderate-intensity physical activity was undertaken 0 191 76.7% 285 63.3%
1 33 13.3% 68 15.1%
2 14 5.6% 45 10.0%
3 +  11 4.4% 52 11.6%
Participants meeting > 150 min of moderate-to-vigorous intensity physical activity per week 68 26.9% 172 37.2%
Continuous variables Mean SD Mean SD
Age (Years) 58 14 60 12
BMI (kg/m2)c 32.2 7.9 30.4 6.1
Physical activity volume (mg) 19.3 6.6 19.6 7.2
Time spent in moderate or vigorous intensity physical activity (minutes/day) 14.9 14.8 21.1 22.3
Time spent in light intensity physical activity (minutes/day) 149.8 54.9 138.8 51.4
Time spent inactive (hours/day) 12.1 1.7 12.6 1.7
Intensity of the most active 10 min (mg) 61.0 39.0 73.6 64.0
Intensity of the most active 30 min (mg) 40.4 25.4 49.6 47.8
Total sleep time (hours/day) 7.2 1.1 6.9 1.1
Sleep Efficiency (%) 85.7 5.2 85.0 5.7
Variability in sleep midpoint (SD in minutes) 120.5 89.5 113.4 84.9
Number of valid days 14 2 14 2
Number of valid nights 13 3 13 3

a WHO clinical progression scale: 3–4 = no continuous supplemental oxygen needed, 5 = continuous supplemental oxygen only, 6 = continuous positive airway pressure ventilation (CPAP), bi-level positive airway pressure (BIPAP) or high flow nasal oxygen, 7–9 = invasive mechanical ventilation (IMV) or extra-corporeal membrane oxygenation (ECMO)

b IMD = Index of Multiple Deprivation

c BMI = body mass index